Io Biotech Stock Performance
| IOBT Stock | USD 0.33 0.04 12.16% |
The company owns a Beta (Systematic Risk) of 0.57, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IO Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding IO Biotech is expected to be smaller as well. At this point, IO Biotech has a negative expected return of -0.0399%. Please make sure to check out IO Biotech's standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if IO Biotech performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days IO Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, IO Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
1 | IO Biotech GAAP EPS of -0.13 beats by 0.25 | 11/14/2025 |
2 | IO Biotech Presents at Jefferies Global Healthcare Conference - TipRanks | 11/18/2025 |
3 | IO Biotech Announces Resignation of Chief Accounting Officer - TipRanks | 11/21/2025 |
4 | IO Biotech Announces Participation in Upcoming December Investor Conferences | 11/26/2025 |
5 | IO Biotech Receives Nasdaq Notice for Bid Price Noncompliance - TipRanks | 12/19/2025 |
6 | IO Biotech receives Nasdaq notice for bid price noncompliance - MSN | 01/06/2026 |
7 | Acquisition by Smith David V of 35144 shares of IO Biotech at 1.5 subject to Rule 16b-3 | 01/07/2026 |
8 | What margin trends mean for IO Biotech Inc. stock - Market Growth Report Weekly Setup with High ROI Potential - moha.gov.vn | 01/13/2026 |
9 | IOBT IO Biotech, Inc. 0.47 on 22 Jan 2026 active intraday mover for traders - Meyka | 01/22/2026 |
| Begin Period Cash Flow | 143.5 M | |
| Total Cashflows From Investing Activities | -44 K |
IO Biotech Relative Risk vs. Return Landscape
If you would invest 90.00 in IO Biotech on October 28, 2025 and sell it today you would lose (57.50) from holding IO Biotech or give up 63.89% of portfolio value over 90 days. IO Biotech is currently does not generate positive expected returns and assumes 20.0313% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than IOBT, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
IO Biotech Target Price Odds to finish over Current Price
The tendency of IOBT Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.33 | 90 days | 0.33 | close to 99 |
Based on a normal probability distribution, the odds of IO Biotech to move above the current price in 90 days from now is close to 99 (This IO Biotech probability density function shows the probability of IOBT Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days IO Biotech has a beta of 0.57. This usually indicates as returns on the market go up, IO Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding IO Biotech will be expected to be much smaller as well. Additionally IO Biotech has an alpha of 0.317, implying that it can generate a 0.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). IO Biotech Price Density |
| Price |
Predictive Modules for IO Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IO Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.IO Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IO Biotech is not an exception. The market had few large corrections towards the IO Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IO Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IO Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.32 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | 0.01 |
IO Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IO Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IO Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IO Biotech generated a negative expected return over the last 90 days | |
| IO Biotech has high historical volatility and very poor performance | |
| IO Biotech has some characteristics of a very speculative penny stock | |
| IO Biotech has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (95.49 M) with loss before overhead, payroll, taxes, and interest of (2.59 M). | |
| IO Biotech currently holds about 170.12 M in cash with (82.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| IO Biotech has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: IOBT IO Biotech, Inc. 0.47 on 22 Jan 2026 active intraday mover for traders - Meyka |
IO Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IOBT Stock often depends not only on the future outlook of the current and potential IO Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IO Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.9 M | |
| Cash And Short Term Investments | 60 M |
IO Biotech Fundamentals Growth
IOBT Stock prices reflect investors' perceptions of the future prospects and financial health of IO Biotech, and IO Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IOBT Stock performance.
| Return On Equity | -2.4 | ||||
| Return On Asset | -0.89 | ||||
| Current Valuation | 13.86 M | ||||
| Shares Outstanding | 71.95 M | ||||
| Price To Book | 28.98 X | ||||
| Gross Profit | (2.59 M) | ||||
| EBITDA | (93.2 M) | ||||
| Net Income | (95.49 M) | ||||
| Cash And Equivalents | 170.12 M | ||||
| Cash Per Share | 5.90 X | ||||
| Total Debt | 1.92 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 20.94 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (82.35 M) | ||||
| Earnings Per Share | (1.34) X | ||||
| Market Capitalization | 26.41 M | ||||
| Total Asset | 67.7 M | ||||
| Retained Earnings | (359.31 M) | ||||
| Working Capital | 45.47 M | ||||
About IO Biotech Performance
Assessing IO Biotech's fundamental ratios provides investors with valuable insights into IO Biotech's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the IO Biotech is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.27) | (1.33) | |
| Return On Capital Employed | (2.27) | (2.16) | |
| Return On Assets | (1.27) | (1.33) | |
| Return On Equity | (2.34) | (2.22) |
Things to note about IO Biotech performance evaluation
Checking the ongoing alerts about IO Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IO Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IO Biotech generated a negative expected return over the last 90 days | |
| IO Biotech has high historical volatility and very poor performance | |
| IO Biotech has some characteristics of a very speculative penny stock | |
| IO Biotech has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (95.49 M) with loss before overhead, payroll, taxes, and interest of (2.59 M). | |
| IO Biotech currently holds about 170.12 M in cash with (82.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| IO Biotech has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: IOBT IO Biotech, Inc. 0.47 on 22 Jan 2026 active intraday mover for traders - Meyka |
- Analyzing IO Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IO Biotech's stock is overvalued or undervalued compared to its peers.
- Examining IO Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IO Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IO Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IO Biotech's stock. These opinions can provide insight into IO Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.